Received Jul 17, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| HEPA | HEP A (HAVRIX) | GLAXOSMITHKLINE BIOLOGICALS | UNK | — | — |
administered adult Havrix to 2-year-old; administered adult Havrix to 2-year-old; This non-serious case was reported by a nurse via call center representative and described the occurrence of adult product administered to child in a 2-year-old patient who received HAV (Havrix adult) for prophylaxis. On an unknown date, the patient received Havrix adult. On an unknown date, an unknown time after receiving Havrix adult, the patient experienced adult product administered to child (Verbatim: administered adult Havrix to 2-year-old) and overdose (Verbatim: administered adult Havrix to 2-year-old). The outcome of the adult product administered to child and overdose were not applicable. This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences. Additional Information: GSK Receipt Date: 18-OCT-2023 The nurse reported that they administered adult Havrix vaccine to 2-year-old, which led to adult product administered to child and overdose.